Valeant Pharmaceuticals Intern...

NYSE: VRX
$23.40
-$0.83 (-3.4%)
Closing price July 13, 2018
Mattel, Valeant, MannKind, and DryShips all posted new 52-week lows on Friday.
Rite Aid, Valeant, Calpine, and Teva all posted new 52-week lows on Thursday.
Frontier Communications, Rite Aid, Valeant, and DryShips all posted new 52-week lows Wednesday.
Valeant, Arena, Teva, and Frontier Communications all posted new 52-week lows on Tuesday.
QEP Resources, Valeant, Vince Holdings, and New York Community Bank all posted new 52-week lows Monday.
Valeant, Sorrento Pharmaceuticals, QEP Resources, and New York Community Bank all posted new 52-week lows Friday.
DryShips, Valeant, Top Ships and Palatin Technologies posted fresh 52-week lows on Friday.
Valeant, DryShips, Novovax, and TopShips posted new 52-week lows Thursday.
DryShips, Valeant Novovax, and L Brands all posted new 52-week lows on Wednesday.
SeaDrill, DryShips, Rite Aid, and Valeant Pharma made new 52-week lows Tuesday.
Rite Aid, J.C. Penney, Valeant, and Cobalt Energy all posted new 52-week lows on Tuesday.
Valeant Pharmaceuticals shares hit a multiyear low on Tuesday after it was announced that Bill Ackman would be selling off his stake in the company and stepping down from the board.
The analysts at Stifel have done some outstanding work on four companies that are oversold to some degree and may be offering investors some solid contrarian value.
Valeant, J.C. Penney, Frontier Communications, and Anthera Pharmaceuticals all posted new 52-week lows Tuesday.
Valeant, DryShips, Frontier Communications, and SeaDrill all posted new 52-week lows on Tuesday.